Company intelligence / Profile preview

Melon

Brooklyn, New York, United Statesmelonsandbox.com ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

Melonfrost has developed a proprietary evolution reactor and AI-powered software that together enable rapid directed evolution of microorganisms. Their approach allows real-time steering of organismal evolution to optimize traits relevant to therapeutics, biomaterials, food production, and energy. The company has raised $7 million in seed funding and filed patents related to artificial neural networks and biotechnology. No direct clinical results reported—company acts as an enabling platform.

Therapeutic areas: Other
Modalities: Microbial therapyBiologic
Industry: Drug Discovery Services

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on Melon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melon.

Explore the full profile